Table of Contents Author Guidelines Submit a Manuscript
Advances in Hematology
Volume 2016, Article ID 7678901, 9 pages
http://dx.doi.org/10.1155/2016/7678901
Research Article

Characterization of IXINITY® (Trenonacog Alfa), a Recombinant Factor IX with Primary Sequence Corresponding to the Threonine-148 Polymorph

1School of Medicine, Department of Hematology/Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
2Haematologic Technologies, Incorporated, Essex Junction, VT 05452, USA
3Department of Chemical and Biomolecular Engineering, University of Nebraska-Lincoln, Lincoln, NE 68588, USA
4Biosciences Division, Emergent BioSolutions Incorporated, Winnipeg, MB, Canada R3T 5Y3
5University of Manitoba, Winnipeg, MB, Canada R3T 2N2

Received 29 September 2015; Accepted 14 January 2016

Academic Editor: David Varon

Copyright © 2016 Dougald M. Monroe et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Dougald M. Monroe, Richard J. Jenny, Kevin E. Van Cott, Shelly Buhay, and Laura L. Saward, “Characterization of IXINITY® (Trenonacog Alfa), a Recombinant Factor IX with Primary Sequence Corresponding to the Threonine-148 Polymorph,” Advances in Hematology, vol. 2016, Article ID 7678901, 9 pages, 2016. https://doi.org/10.1155/2016/7678901.